GURUFOCUS.COM » STOCK LIST » Industrials » Transportation » CryoPort Inc (NAS:CYRX) » Definitions » Net Current Asset Value

CryoPort (CryoPort) Net Current Asset Value : $0.82 (As of Dec. 2023)


View and export this data going back to 1993. Start your Free Trial

What is CryoPort Net Current Asset Value?

In calculating the Net Current Asset Value (NCAV), Benjamin Graham means a company's current assets (such as cash, marketable securities, and inventories) minus its total liabilities (including preferred stock, minority interest, and long-term debt).

CryoPort's net current asset value per share for the quarter that ended in Dec. 2023 was $0.82.

The historical rank and industry rank for CryoPort's Net Current Asset Value or its related term are showing as below:

CYRX' s Price-to-Net-Current-Asset-Value Range Over the Past 10 Years
Min: 6.58   Med: 13.86   Max: 20.84
Current: 20.5

During the past 13 years, the highest Price-to-Net-Current-Asset-Value Ratio of CryoPort was 20.84. The lowest was 6.58. And the median was 13.86.

CYRX's Price-to-Net-Current-Asset-Value is ranked worse than
86.04% of 308 companies
in the Transportation industry
Industry Median: 3.795 vs CYRX: 20.50

CryoPort Net Current Asset Value Historical Data

The historical data trend for CryoPort's Net Current Asset Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CryoPort Net Current Asset Value Chart

CryoPort Annual Data
Trend Mar14 Mar15 Mar16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Net Current Asset Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.50 -0.64 4.27 2.13 0.82

CryoPort Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Current Asset Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.13 2.00 1.57 1.26 0.82

Competitive Comparison of CryoPort's Net Current Asset Value

For the Integrated Freight & Logistics subindustry, CryoPort's Price-to-Net-Current-Asset-Value, along with its competitors' market caps and Price-to-Net-Current-Asset-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CryoPort's Price-to-Net-Current-Asset-Value Distribution in the Transportation Industry

For the Transportation industry and Industrials sector, CryoPort's Price-to-Net-Current-Asset-Value distribution charts can be found below:

* The bar in red indicates where CryoPort's Price-to-Net-Current-Asset-Value falls into.



CryoPort Net Current Asset Value Calculation

CryoPort's Net Current Asset Value (NCAV) per share for the fiscal year that ended in Dec. 2023 is calculated as

Net Current Asset Value Per Share(A: Dec. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(535.112-468.721-0-26.275)/48.971
=0.82

CryoPort's Net Current Asset Value (NCAV) per share for the quarter that ended in Dec. 2023 is calculated as

Net Current Asset Value Per Share(Q: Dec. 2023 )
=(Total Current Assets-Total Liabilities-Minority Interest-Preferred Stock)/Shares Outstanding (EOP)
=(535.112-468.721-0-26.275)/48.971
=0.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CryoPort  (NAS:CYRX) Net Current Asset Value Explanation

Benjamin Graham first discussed net current asset value (NCAV) in the 1934 edition of "Security Analysis", which he coauthored with David Dodd. In the book, (net) current asset value is defined as:" current assets alone, minus all liabilities and claims ahead of the issue."

The common definition of NCAV is: NCAV = current assets – [total liabilities + minority interest + preferred stock]

Net current assets exclude not only the intangible assets but also the fixed and miscellaneous assets. In addition, Graham believed that preferred stock belongs on the liability side of the balance sheet, not as part of capital and surplus. In "Security Analysis", preferred stock is dubbed "an imperfect creditorship position" that is best placed on the balance sheet alongside funded debt.

One research study, covering the years 1970 through 1983 showed that portfolios picked at the beginning of each year, and held for one year, returned 29.4 percent, on average, over the 13-year period, compared to 11.5 percent for the S&P 500 Index. Other studies of Graham’s strategy produced similar results.

Benjamin Graham looked for companies whose market values were less than two-thirds of their Net-Net Working Capital. They are collected under our Net-Net screener.


CryoPort Net Current Asset Value Related Terms

Thank you for viewing the detailed overview of CryoPort's Net Current Asset Value provided by GuruFocus.com. Please click on the following links to see related term pages.


CryoPort (CryoPort) Business Description

Traded in Other Exchanges
Address
112 Westwood Place, Suite 350, Brentwood, TN, USA, 37027
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.
Executives
Robert J Hariri director 341 MENDHAM ROAD, BERNARDSVILLE NJ 07924
Jerrell Shelton director, officer: President, CEO C/O NETRATINGS INC, 120 WEST 45TH STREET 35TH FLOOR, NEW YORK NY 10036
Richard J Berman director 305 COLLEGE ROAD EAST, PRINCETON NJ 08540
Robert Stefanovich officer: Chief Financial Officer
Mark W Sawicki officer: Chief Scientific Officer 3303 LAKEPOINTE DRIVE, BELMONT NC 28012
Blackstone Holdings Ii L.p. 10 percent owner C/O BLACKSTONE INC., 345 PARK AVENUE, NEW YORK NY 10154
Blackstone Tactical Opportunities Fund - Fd L.p. 10 percent owner C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154
Daniel M Hancock director 7729 S. BELMONT, INDIANAPOLIS IN 46217
Edward J Zecchini director 20382 BARENTS SEA CIRCLE, LAKE FOREST CA 92630
Linda Baddour director PRA INTERNATIONAL, 12120 SUNSET HILLS ROAD, SUITE 600, RESTON VA 20190
Ramkumar Mandalam director 4344 PICKEREL DRIVE, UNION CITY CA 94587
Ram M. Jagannath director C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154
Stephen A Schwarzman 10 percent owner C/O BLACKSTONE INC., 345 PARK AVE, NEW YORK NY 10154
Blackstone Tactical Opportunities Associates Iii - Nq L.p. 10 percent owner C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154
Blackstone Freeze Parent L.p. 10 percent owner C/O THE BLACKSTONE GROUP INC., 345 PARK AVENUE, NEW YORK NY 10154